Management of post-myocardial infarction ventricular septal rupture

William M Wilson1, Eric M Horlick

  • 1Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.

Insights

Transcatheter device closure for ventricular septal rupture (VSR) after myocardial infarction offers an alternative to surgery. While technically successful, early closure is linked to high mortality; outcomes improve in the subacute phase or for post-surgical leaks.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Ventricular septal rupture (VSR) following acute myocardial infarction (MI) carries a high mortality risk.
  • Early surgical repair is the traditional recommendation for VSR, irrespective of hemodynamic status.
  • Transcatheter device closure has emerged as a less invasive alternative to surgical VSR repair.

Purpose of the Study:

  • To review the efficacy and safety of transcatheter device closure for VSR post-MI.
  • To compare outcomes of transcatheter closure versus surgical repair in different clinical scenarios.
  • To evaluate the optimal timing and patient selection for transcatheter VSR closure.

Main Methods:

  • Review of existing literature and clinical data on transcatheter device closure for VSR.
  • Analysis of procedural success rates, complication rates, and in-hospital mortality.
  • Comparison of outcomes based on the timing of intervention (early vs. subacute phase) and patient characteristics.

Main Results:

  • Transcatheter VSR closure demonstrates a high technical success rate with a low complication rate.
  • Early transcatheter closure is associated with high in-hospital mortality.
  • Optimal outcomes are observed in the subacute phase post-MI or for managing post-surgical patch leaks, potentially due to patient selection bias.

Conclusions:

  • Transcatheter closure is a viable option for VSR, particularly in non-surgical candidates or for post-surgical leaks.
  • A hybrid strategy combining early surgical closure with subsequent transcatheter management of residual leaks is favored.
  • Long-term outcomes are favorable for patients who survive hospital discharge, regardless of the initial treatment approach.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
418
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
431
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
516
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
490
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
424